Overview

Oxymorphone Extended Release (ER) in Opioid-Naive Patients With Chronic Pain

Status:
Completed
Trial end date:
2004-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if oxymorphone ER is effective and safe in treating chronic pain in opioid-naive patients.
Phase:
Phase 3
Details
Lead Sponsor:
Endo Pharmaceuticals
Treatments:
Analgesics, Opioid
Oxymorphone